These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Understanding the impact of mannitol on physical stability and aerosolization of spray-dried protein powders for inhalation. Arte KS, Tower CW, Mutukuri TT, Chen Y, Patel SM, Munson EJ, Tony Zhou Q. Int J Pharm; 2024 Jan 25; 650():123698. PubMed ID: 38081559 [Abstract] [Full Text] [Related]
3. Inhalable spray-dried formulation of D-LAK antimicrobial peptides targeting tuberculosis. Kwok PC, Grabarek A, Chow MY, Lan Y, Li JC, Casettari L, Mason AJ, Lam JK. Int J Pharm; 2015 Aug 01; 491(1-2):367-74. PubMed ID: 26151107 [Abstract] [Full Text] [Related]
4. Inhalable Nanoparticles/Microparticles of an AMPK and Nrf2 Activator for Targeted Pulmonary Drug Delivery as Dry Powder Inhalers. Acosta MF, Abrahamson MD, Encinas-Basurto D, Fineman JR, Black SM, Mansour HM. AAPS J; 2020 Nov 16; 23(1):2. PubMed ID: 33200330 [Abstract] [Full Text] [Related]
5. Advanced spray-dried design, physicochemical characterization, and aerosol dispersion performance of vancomycin and clarithromycin multifunctional controlled release particles for targeted respiratory delivery as dry powder inhalation aerosols. Park CW, Li X, Vogt FG, Hayes D, Zwischenberger JB, Park ES, Mansour HM. Int J Pharm; 2013 Oct 15; 455(1-2):374-92. PubMed ID: 23820131 [Abstract] [Full Text] [Related]
6. Effect of Particle Formation Process on Characteristics and Aerosol Performance of Respirable Protein Powders. Brunaugh AD, Wu T, Kanapuram SR, Smyth HDC. Mol Pharm; 2019 Oct 07; 16(10):4165-4180. PubMed ID: 31448924 [Abstract] [Full Text] [Related]
7. Particle engineering of materials for oral inhalation by dry powder inhalers. I-Particles of sugar excipients (trehalose and raffinose) for protein delivery. Ogáin ON, Li J, Tajber L, Corrigan OI, Healy AM. Int J Pharm; 2011 Feb 28; 405(1-2):23-35. PubMed ID: 21129458 [Abstract] [Full Text] [Related]
8. Development of drug alone and carrier-based GLP-1 dry powder inhaler formulations. Babenko M, Alany RG, Calabrese G, Kaialy W, ElShaer A. Int J Pharm; 2022 Apr 05; 617():121601. PubMed ID: 35181460 [Abstract] [Full Text] [Related]
9. Fragmented particles containing octreotide acetate prepared by spray drying technique for dry powder inhalation. Hou A, Li L, Huang Y, Singh V, Zhu C, Pan X, Quan G, Wu C. Drug Deliv Transl Res; 2018 Jun 05; 8(3):693-701. PubMed ID: 29600480 [Abstract] [Full Text] [Related]
10. Heat-Stable Dry Powder Oxytocin Formulations for Delivery by Oral Inhalation. Fabio K, Curley K, Guarneri J, Adamo B, Laurenzi B, Grant M, Offord R, Kraft K, Leone-Bay A. AAPS PharmSciTech; 2015 Dec 05; 16(6):1299-306. PubMed ID: 25776985 [Abstract] [Full Text] [Related]
11. [Development of an Inhalation Dry Powder Preparation Method without Heat-drying Process]. Ito T. Yakugaku Zasshi; 2023 Dec 05; 143(4):353-358. PubMed ID: 37005236 [Abstract] [Full Text] [Related]
12. Design, characterization, and aerosol dispersion performance modeling of advanced spray-dried microparticulate/nanoparticulate mannitol powders for targeted pulmonary delivery as dry powder inhalers. Li X, Vogt FG, Hayes D, Mansour HM. J Aerosol Med Pulm Drug Deliv; 2014 Apr 05; 27(2):81-93. PubMed ID: 24502451 [Abstract] [Full Text] [Related]
13. Phospholipid-based pyrazinamide spray-dried inhalable powders for treating tuberculosis. Eedara BB, Tucker IG, Das SC. Int J Pharm; 2016 Jun 15; 506(1-2):174-83. PubMed ID: 27091294 [Abstract] [Full Text] [Related]
14. Design, characterization, and aerosol dispersion performance modeling of advanced co-spray dried antibiotics with mannitol as respirable microparticles/nanoparticles for targeted pulmonary delivery as dry powder inhalers. Li X, Vogt FG, Hayes D, Mansour HM. J Pharm Sci; 2014 Sep 15; 103(9):2937-2949. PubMed ID: 24740732 [Abstract] [Full Text] [Related]
15. Spray drying siRNA-lipid nanoparticles for dry powder pulmonary delivery. Zimmermann CM, Baldassi D, Chan K, Adams NBP, Neumann A, Porras-Gonzalez DL, Wei X, Kneidinger N, Stoleriu MG, Burgstaller G, Witzigmann D, Luciani P, Merkel OM. J Control Release; 2022 Nov 15; 351():137-150. PubMed ID: 36126785 [Abstract] [Full Text] [Related]
16. Design, physicochemical characterization, and optimization of organic solution advanced spray-dried inhalable dipalmitoylphosphatidylcholine (DPPC) and dipalmitoylphosphatidylethanolamine poly(ethylene glycol) (DPPE-PEG) microparticles and nanoparticles for targeted respiratory nanomedicine delivery as dry powder inhalation aerosols. Meenach SA, Vogt FG, Anderson KW, Hilt JZ, McGarry RC, Mansour HM. Int J Nanomedicine; 2013 Nov 15; 8():275-93. PubMed ID: 23355776 [Abstract] [Full Text] [Related]
17. Computational Fluid Dynamics (CFD) Simulations of Spray Drying: Linking Drying Parameters with Experimental Aerosolization Performance. Longest PW, Farkas D, Hassan A, Hindle M. Pharm Res; 2020 May 21; 37(6):101. PubMed ID: 32440940 [Abstract] [Full Text] [Related]
18. Characterization and aerosol dispersion performance of advanced spray-dried chemotherapeutic PEGylated phospholipid particles for dry powder inhalation delivery in lung cancer. Meenach SA, Anderson KW, Zach Hilt J, McGarry RC, Mansour HM. Eur J Pharm Sci; 2013 Jul 16; 49(4):699-711. PubMed ID: 23707466 [Abstract] [Full Text] [Related]
19. Low powder mass filling of dry powder inhalation formulations. Eskandar F, Lejeune M, Edge S. Drug Dev Ind Pharm; 2011 Jan 16; 37(1):24-32. PubMed ID: 20738180 [Abstract] [Full Text] [Related]
20. Formulating Inhalable Dry Powders Using Two-Fluid and Three-Fluid Nozzle Spray Drying. Leng D, Thanki K, Foged C, Yang M. Pharm Res; 2018 Nov 01; 35(12):247. PubMed ID: 30386927 [Abstract] [Full Text] [Related] Page: [Next] [New Search]